| Literature DB >> 25780658 |
Tebogo Elvis Kwape1, Padmaja Chaturvedi1, Macharia Kamau2, Runner Majinda3.
Abstract
OBJECTIVE: The study was carried out to evaluate the hepatoprotective and antioxidant potential of Ziziphus mucronata (ZM) fruit extract.Entities:
Keywords: Ziziphus mucronata; antioxidants; dimethoate; oxidative stress; phenol content; toxicity
Year: 2013 PMID: 25780658 PMCID: PMC4331958 DOI: 10.3831/KPI.2013.16.001
Source DB: PubMed Journal: J Pharmacopuncture ISSN: 2093-6966
Fig. 1TLC-DPPH assay showing the antioxidant activities of different concentrations of ZMFE spotted on a TLC sheet.
Fig. 2Percent inhibition of DPPH by different concentrations of Z. mucronata fruit extracts after 30 min.
Total phenol content of ZM fruit extracts
| Fruit extract | TPC (mg GAE/g) |
|---|---|
| 70% methanol | 250 ± 4.3 |
| 100% methanol | 240 ± 3.2 |
| 50% methanol/chloroform | 100 ± 2.4 |
| Chloroform | 57 ± 0.9 |
| 50% hexane chloroform | 48 ± 1.2 |
| Hexane | 30 ± 0.3 |
* Values are numbers or means ± SDs.
In-vitro ABTS free-radical scavenging activity of ZM extracts
| Plant part | Test extract | IC50 (㎍/㎖) |
|---|---|---|
| Fruit extract | 100% methanol | 7.21 |
| 50% methanol/chloroform | 30.34 | |
| 100% chloroform | 50.13 | |
| 50% hexane/chloroform | 60.55 | |
| 100% hexane | 80.22 |
The values are means of three replicates ± SDs.
Extracts were tested at 2.5, 5, 10, 25, 50 and 100 ㎍/㎖.
Reference standard (gallic acid) was tested at 1, 2, 4, 8 and 16 ㎍/㎖.
Effect of ZMFM on serum marker parameters of dimethoate-treated rat
| Groups | TBARS (nmol/ml) | SGOT (U/L) | SGPT (U/L) | ALP (U/L) |
|---|---|---|---|---|
| NC | 0.690 ± 0.003 | 46.0 ± 2.8 | 48.0 ± 0.7 | 50.0 ± 2. |
| DC | 4.868 ± 0.275** | 349.0 ± 3.2** | 330.0 ± 0.9** | 670.0 ±1.4** |
| E1 | 3.172 ± 0.008** | 190.0 ± 2.8** | 175.0 ± 1.7** | 240.0 ± 2.6** |
| E2 | 1.900 ± 0.002**/a | 65.0 ± 0.6aa | 60.0 ± 1.6aa | 90.0 ± 1.6*/ aa |
| E3 | 0.992± 0.007*/aa | 48.0 ± 1.2aa | 43.0 ± 2.1aa | 70.0 ± 2.3*/aa |
| EO | 0.644 ± 0.001a | 45. ± 1.1aa | 46.0 ± 0.1aa | 49.0 ± 0.1a |
Values are expressed as means ± SEMs, n = 5 for each treatment, (P < 0.05*,P < 0.001**) compared with normal control (NC) and (P < 0.05a,P < 0.001aa ) compared with dimethoate control (DC).
E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), E3 (300 mg/kg.bw + DM), and EO (300 mg/kg.bw).
Effect of ZMFM on GSH, vitamin C and vitamin E of dimethoate-treated rats
| Groups | Vitamin E (mg/ml) | Vitamin C (mg/ml) | GSH (mg/ml) |
|---|---|---|---|
| NC | 5.00 ± 0.11 | 6.28 ± 0.02 | 55.0 ± 0.1 |
| DC | 1.00 ± 0.00* | 2.03 ± 0.15* | 20.0 ± 0.3* |
| E1 | 1.35 ± 0.01* | 2.10 ± 0.21* | 30.0 ± 0.4*/a |
| E2 | 1.39 ± 0.02* | 3.00 ± 0.00* | 37.0 ± 0.1*/a |
| E3 | 1.45 ± 0.10* | 3.01± 0.01* | 40.0 ± 0.6*/aa |
Values are expressed as means ± SEMs, n = 5 for each treatment, (P < 0.05*,P < 0.001**) compared with normal control (NC) and (P < 0.05a,P < 0.001aa ) compared with dimethoate control (DC).
E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), and E3 (300 mg/kg.bw + DM).
Effect of ZMFM on antioxidant enzymes: SOD and catalase in plasma from dimethoate-treated rats
| Groups | SOD (U/mg) | Catalase (Umg-1 ) |
|---|---|---|
| NC | 5.821 ± 0.012 | 403.6 ± 3.67 |
| DC | 14.210 ± 0.029* | 731.6 ± 2.52** |
| E1 | 12.100 ± 0.021**/a | 580.2 ± 2.30*/a |
| E2 | 9.170 ± 0.050**/aa | 457.9 ± 2.33aa |
| E3 | 7.840 ± 0.018*/a | 407.2 ± 4.30aa |
Values are expressed as means ± SEMs, n = 5 for each treatment (P < 0.05*,P < 0.001**) compared with normal control (NC) and (P < 0.05a,P < 0.001aa ) compared with dimethoate control (DC).
E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), and E3 (300 mg/kg.bw + DM).
Effect of ZMFM on lipid and lipoprotein profiles in serum from dimethoate-treated rats
| Groups | HDL (mg/dL) | LDL (mg/dL) | Cho (mg/dL) | Tp (gm/dL ) | Trig(mg/dL) |
|---|---|---|---|---|---|
| NC | 59.00 ± 1.00 | 9.00 ± 3.00 | 110.00 ± 1.78 | 8.10 ± 0.12 | 61.0 ± 7.8 |
| DC | 20.00 ±0.37** | 150.00 ± 12.20** | 162.00 ± 9.15** | 2.00 ± 0.02* | 120.0 ± 6.3** |
| E1 | 38.00 ± 0.37** | 67.00 ± 9.41**/aa | 158.00 ± 8.39**/aa | 3.40 ± 0.13* | 90.0 ± 9.4* |
| E2 | 47.00 ±0.45a | 30.00 ± 2.13**/aa | 118.00 ± 6.24*/aa | 6.50 ± 0.07a | 76.0 ± 7.6aa |
| E3 | 52.00 ± 2.74a | 22.00 ± 4.19*/aa | 96.00 ± 5.31*/aa | 7.00 ± 0.01a | 69.0 ± 5.3aa |
Values are expressed as means ± SEMs, n = 5 for each treatment (P < 0.05*,P < 0.001**) compared with normal control and (P < 0.05a,P < 0.001aa ) when compared with dimethoate control.
E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), and E3 (300 mg/kg.bw + DM).
Effects of ZMFM on plasma cholinesterase activity on dim -ethoat-treated rats
| Experimental groups | Cholinesterase activity (Umg-1 ) |
|---|---|
| NC | 30200 ± 28 |
| DC | 6657 ± 34* |
| E1 | 9914 ± 40* |
| E2 | 15262 ± 12*/a |
| E3 | 21620 ± 26*/a |
Values are expressed as means ± SEMs, n = 5 for each treatment, (P < 0.05*,P < 0.001**) compared with normal control and (P < 0.05a,P < 0.001aa ) compared with dimethoate control.
E1 (100 mg/kg.bw + DM), E2 (200 mg/ kg.bw extract + DM), and E3 (300 mg/kg.bw + DM).
Fig. 3Figure 3